InTouch Health has announced the launch of the ControlStation (CS) App for iPad, making it easier for doctors to provide real-time, acute telemedicine consults with patients. From a single interface, doctors can now connect from iPads and iPad Minis to provide patient care through any of the Company’s Food and Drug Administration (FDA)-cleared, purpose-built remote presence devices. An interface designed specifically for acute care telemedicine, it integrates clinical patient data and medical radiology imaging tools through a single user login.
Olympus received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Articulating HD 3-D Laparoscopic Surgical Video System. It delivers value to surgeons and patients by reducing surgical errors and improving the speed, accuracy and precision of surgical tasks such as dissection, grasping and suturing when compared with traditional 2-D surgical systems, based on internal Olympus testing conducted using a simulated surgical model. This is accomplished by restoring natural 3-D vision and depth perception when performing laparoscopic procedures and is independent of a surgeon’s skill level.

Medtronic Inc. announced market release of the CardioGuide Implant System, a novel real-time navigation system for cardiac resynchronization therapy pacemakers and defibrillators (CRT-P and CRT-D), in the United States and Canada. The system helps physicians determine the most appropriate location for left-ventricular lead placement by generating 3-D images of the cardiac veins; enhanced software for the system will be commercially available later this year that also analyzes the motion of select cardiac vessels on the left side of the heart. Clinical studies have shown that appropriate left-ventricular lead placement may improve CRT response in heart failure patients.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
CardioFocus Inc. announced that as of late 2012, more than 1,000 clinical cases have been performed worldwide using the HeartLight technology. The company hosted an expert symposium to review the clinical application of HeartLight and key observations made during the first 1,000 cases in January.

According to a new study published online in the Journal of the American College of Radiology, any efficiencies in physician interpretation and diagnosis gained when different providers interpret different medical imaging scans performed on the same patient are minute and vary by procedure.
MIM Software Inc. has announced its software release MIM 6 is now available. Users in all areas of medical imaging can benefit from tools for deformable evaluation and correction, magnetic resonance/computed tomography (MR/CT) deformable and automated series management.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
American Well has announced a new telehealth pilot program at Massachusetts General Hospital to better monitor heart failure patients by making physicians available to patients through live, real-time video visits.
One thousand days, 1,000 C-arms: this is the result three years after the introduction of the Ziehm Solo. As one of the most compact and flexible C-arms, the Ziehm Solo adjusts to the special demands and requirements of clinics. More and more users from orthopedics and trauma opt for Ziehm Imaging’s multi-talent for intraoperative imaging. The 1,000th Ziehm Solo will be delivered to the Clinica Santa Elena in Malaga, Spain.
Cancer survivors who had chest radiation are nearly twice as likely to die in the years after having major heart surgery as similar patients who didn't have radiation, according to research in the American Heart Association journal Circulation.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
W. L. Gore & Associates Inc. has received U.S. Food and Drug Administraion (FDA) approval for the new large diameter 35 mm trunk-ipsilateral leg and 36 mm aortic extender components, as well as the lower profile 31 mm diameter trunk-ipsilateral leg and 32 mm aortic extender components of the Gore Excluder AAA Endoprosthesis. The new components provide physicians with a proven and durable endovascular option to treat abdominal aortic aneurysms (AAAs).
Tyrx Inc. has received a license from Health Canada to market its new AigisRx R Fully Resorbable Antibacterial Envelope technology with implantable electronic devices (IEDs). The AigisRx R Antibacterial Envelope is specifically designed to stabilize IEDs while also releasing antimicrobial agents to help provide protection from microbial colonization of the device during surgical implantation. Tyrx is the leader in the commercialization of implantable medical devices intended to help reduce surgical site infections.
The FREEDOM trial, the first long-term, comparative study of its kind exclusively for patients with diabetes and advanced multivessel coronary artery disease (CAD) revealed that diabetics with CAD live longer and are less likely to suffer a non-fatal heart attack when treated with bypass surgery instead of drug-eluting stents (DES), tiny, medicine-coated mesh tubes that prop open clogged arteries.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Samsung Electronics America Inc. announced the Samsung Ugeo H60, the first ultrasound system integrating Samsung technology and design introduced to the U.S. medical imaging market. The Samsung Ugeo H60 ensures superior imaging performance and a sleek design that provides users with a fast, accurate and intuitive ultrasound experience.
Angiotech Pharmaceuticals Inc. announced that it entered into a definitive agreement to sell certain of its subsidiaries, comprising Angiotech's interventional products business, to Argon Medical Devices Inc., a portfolio company of RoundTable Healthcare Partners, for $362.5 million in cash consideration. Angiotech expects the transaction will close prior to the end of April 2013.
Archimedes IndiGo — the physician and patient decision-support tool created by Archimedes, Inc. — was chosen last summer as the risk-assessment engine for the new $100,000 mobile app challenge sponsored by the Office of the National Coordinator (ONC). As part of the U.S. Department of Health and Human Services' Million Hearts "Risk Check Challenge," the ONC invited developers to create a mobile app that would help consumers take a heart-health risk assessment, direct them to health-screening locations in their community and use the results to work with their doctor to develop a plan for improving their heart health.